{"url_path":"/sec/ogen/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 **","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1174940/0001493152-26-021967-index.html","accession_number":"0001493152-26-021967","cik":"0001174940","ticker":"OGEN","issuer_name":"ORAGENICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1174940/0001493152-26-021967-index.html","primary_entity_key":"0001174940","primary_entity_name":"ORAGENICS INC"},"word_count":35,"has_tables":true,"body_markdown":"**ITEM\n5.**\n**OTHER\nINFORMATION**\n\n \n\n(c) During\nthe quarter ended March 31, 2026, no director or officer adopted\nor terminated\na “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in"}